PDF Return
C. 96
To: Board of Supervisors
From: Anna Roth, Health Services Director
Date: January  5, 2021
The Seal of Contra Costa County, CA
Contra
Costa
County
Subject: Purchase Order with ASD Specialty Healthcare, LLC

APPROVE OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR RECOMMENDATION OF BOARD COMMITTEE

Action of Board On:   01/05/2021
APPROVED AS RECOMMENDED OTHER
Clerks Notes:

VOTE OF SUPERVISORS

AYE:
John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor
Contact: Jaspreet Benepal, 925-370-5101
cc: Irene Segovia     Marcy Wilhelm    
I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED:     January  5, 2021
Monica Nino, County Administrator
 
BY: , Deputy

 

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Purchasing Agent, on behalf of the Health Services Department, to execute a purchase order with ASD Specialty Healthcare, LLC., in an amount not to exceed $295,000 for the purchase of Remdesivir medication for treatment of COVID-19 patients, for the period from January 1, 2021 through December 31, 2021.

FISCAL IMPACT:

This purchase order will result in an annual expenditure of up to $295,000 and will be 100% funded by Hospital Enterprise Fund I revenues.

BACKGROUND:

Contra Costa Regional Medical Center (CCRMC) Pharmacy Department has been purchasing Remdesivir for the treatment of COVID-19 patients at CCRMC from ASD Healthcare. ASD Healthcare is the only Federal Government authorized distributer. Remdesevir prevents the virus from producing a particular enzyme that is necessary for the virus to replicate itself. Once this happens, the virus is no longer able to spread within the body. Research shows that when patients with moderate COVID-19 receive remdesivir, their symptoms improve more quickly. The drug has also been shown to shorten the duration of patient hospital stays. Among severely ill COVID-19 patients, remdesivir has been associated with fewer deaths.  
  
Only hospitalized COVID-19 patients may be treated with remdesivir, whether they have mild, moderate or severe disease.  
  
ASD by the FDA ruling is the sole source for providing remdesevir. Wholesalers do not carry this medication by the FDA’s decision at this time.

CONSEQUENCE OF NEGATIVE ACTION:

If this contract is not approved, CCRMC use Remdesivir to treat COVID-19 patients causing a negative impact in the health of patients.

AgendaQuick©2005 - 2024 Destiny Software Inc., All Rights Reserved